Chapter 13 : Exploiting Molecular Mimicry in Targeting Carbohydrate Antigens

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:
Zoom in

Exploiting Molecular Mimicry in Targeting Carbohydrate Antigens, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555818074/9781555811945_Chap13-1.gif /docserver/preview/fulltext/10.1128/9781555818074/9781555811945_Chap13-2.gif


Carbohydrate antigens are potential targets for preventive vaccination. However, carbohydrates alone are not capable of inducing a sufficient anamnestic or secondary immune response and require extensive adjuvanticity to convert them into T-cell-dependent (TD) antigens. This chapter reviews aspects of an alternative approach to induction of responses that target carbohydrate antigens by using peptide or polypeptide surrogates that mimic carbohydrate structures. Emphasis is on studies that elucidate basic mechanisms or immune parameters associated with vaccination with surrogates of glycosphingolipid constituents that may be applied to a variety of antigenic systems. The chapter shows that peptide mimotopes can induce cross-reactive carbohydrate responses that are able to protect mice from lethal bacterial infection or can induce humoral responses with components that are capable of binding to envelope glycoproteins of the human immunodeficiency virus, neutralizing cell-free virus. It illustrates that the Arg-containing peptides K61106 and K61107 also bind to the anti-sLeX Ab FH-6. Peptide mimics of carbohydrates may have several advantages over the carbohydrate itself for induction of carbohydrate-specific immunity: relative ease of production and induction of long-lasting, high-affinity IgG responses. Peptides that mimic carbohydrate structures have further significant advantages as vaccines compared with carbohydrate-protein conjugates or anti-Id Abs. Not all peptides identified as antigen mimics induce PS cross-reactive immune responses.

Citation: Cunto-Amesty G, Kieber-Emmons T. 2000. Exploiting Molecular Mimicry in Targeting Carbohydrate Antigens, p 175-196. In Cunningham M, Fujinami R (ed), Molecular Mimicry, Microbes, and Autoimmunity. ASM Press, Washington, DC. doi: 10.1128/9781555818074.ch13

Key Concept Ranking

Major Histocompatibility Complex
Pneumococcal Conjugate Vaccine
Amino Acids
Immune Response
Highlighted Text: Show | Hide
Loading full text...

Full text loading...


1. Abdel-Motal, U. M.,, L. Berg,, A. Rosen,, M. Bengtsson,, C. J. Thorpe,, J. Kihlberg,, J. Dahmen,, G. Mag-nusson,, K. A. Karlsson,, and M. Jondal. 1996. Immunization with glycosylated Kb-binding peptides generates carbohydrate-specific, unrestricted cytotoxic T cells. Eur. J. Immunol. 26:544551.
2. Adluri, S.,, F. Helling,, S. Ogata,, S. Zhang,, S. H. Itzkowitz,, K. O. Lloyd,, and P. O. Livingston. 1995. Immunogenecity of synthetic TF-KLH (keyhole limpet hemocyanin) and sTn-KLH conjugates in colorectal carcinoma patients. Cancer Immunol. Immunother. 41:185192.
3. Agadjanyan, M.,, P. Luo,, M. A. Westerink,, L. A. Carey,, W. Hutchins,, Z. Steplewski,, D. B. Weiner,, and T. Kieber-Emmons 1997. Peptide mimicry of carbohydrate epitopes on human immunodeficiency virus. Nat. Biotechnol. 15:547551.
4. An, L. L.,, A. P. Hudson,, R. A. Prendergast,, T. P. O'Brien,, E. S. Stuart,, H. J. Whittum,, and A. B. MacDonald. 1997. Biochemical and functional antigenic mimicry by a polyclonal anti-idiotypic antibody for chlamydial exoglycolipid antigen. Pathobiology 65:229240.
5. Apicella, M. A.,, J. M. GrifHss,, and H. Schneider. 1994. Isolation and characterization of lipopolysaccha-rides, lipooligosaccharides, and lipid A. Methods Enzymol. 235:242252.
6. Apostolopoulos, V.,, S. A. Lofthouse,, V. Popvski,, G. Chelvanayagam,, M. S. Sandrin,, and I. F. McKenzie. 1998. Peptide mimics of a tumor antigen induce functional cytotoxic T cells. Nat. Biotechnol. 16:276280.
7. Apostolopoulos, V.,, C. Osinski,, and I. F. McKenzie. 1998. MUC1 cross-reactive Gal alpha(l,3)Gal antibodies in humans switch immune responses from cellular to humoral. Nat. Med. 4:315320.
8. Apostolopoulos, V.,, M. S. Sandrin,, and I. F. McKenzie. 1999. Carbohydrate/peptide mimics: effect on MUC1 cancer immunotherapy. J. Mol. Med. 77:427436.
9. Apostolopoulos, V.,, M. S. Sandrin,, and I. F. McKenzie. 1999. Mimics and cross reactions of relevance to tumour immunotherapy. Vaccine 18:268275.
10. Appelmelk, B. J.,, S. I. Simoons,, R. Negrini,, A. P. Moran,, G. O. Aspinall,, J. G. Forte,, V. T. De,, H. Quan,, T. Verboom,, J. J. Maaskant,, P. Ghiara,, E. J. Kuipers,, E. Bloemena,, T. M. Tadema,, R. R. Townsend,, K. Tyagarajan,, J. J. Crothers,, M. A. Monteiro,, A. Savio,, and G. J. De. 1996. Potential role of molecular mimicry between Helicobacter pylori lipopolysaccharide and host Lewis blood group antigens in autoimmunity. Infect. Immun. 64:20312040.
11. Burritt, J. B.,, C. W. Bond,, K. W. Doss,, and A. J. Jesaitis. 1996. Filamentous phage display of oligopeptide libraries. Anal. Biochem. 238:113.
12. Cagas, P.,, and C. A. Bush. 1992. Conformations of type 1 and type 2 oligosaccharides from ovarian cyst glycoprotein by nuclear Overhauser effect spectroscopy and Tl simulations. Biopolymers 32:277292.
13. Cagas, P.,, and C. A. Bush. 1990. Determination of the conformation of Lewis blood group oligosaccharides by simulation of two-dimensional nuclear Overhauser data. Biopolymers 30:11231138.
14. Castano, A. R.,, S. Tangri,, J. E. W. Miller,, H. R. Holcombe,, M. R. Jackson,, W. D. Huse,, M. Kronenberg,, and P. A. Peterson. 1995. Peptide binding and presentation by mouse CD1. Science 269:223226.
15. Chapman, P. B.,, and A. N. Houghton. 1991. Induction of IgG antibodies against GD3 ganglioside in rabbits by an anti-idiotypic monoclonal antibody. J. Clin. Investig. 88:186192.
16. Cheng, H. L.,, A. K. Sood,, R. E. Ward,, T. Kieber-Emmons,, and H. Kohler. 1988. Structural basis of stimulatory anti-idiotypic antibodies. Mol. Immunol. 25:3340.
17. Cheung, N. K.,, A. Canete,, I. Y. Cheung,, J. N. Ye,, and C. Liu. 1993. Disialoganglioside GD2 anti-idiotypic monoclonal antibodies. Int. J. Cancer 54:499505.
18. Cheung, N. K.,, I. Y. Cheung,, A. Canete,, S. J. Yeh,, B. Kushner,, M. A. Bonilla,, G. Heller,, and S. M. Larson. 1994. Antibody response to murine anti-GD2 monoclonal antibodies: correlation with patient survival. Cancer Res. 54:22282233.
19. Cortese, R.,, P. Monaci,, A. Nicosia,, A. Luzzago,, F. Felici,, G. Galfre,, A. Pessi,, A. Tramontano,, and M. Sollazzo. 1995. Identification of biologically active peptides using random libraries displayed on phage. Curr. Opin. Biotechnol. 6:7380.
20. Craig, L.,, P. C. Sanschagrin,, A. Rozek,, S. Lackie,, L. A. Kuhn,, and J. K. Scott. 1998. The role of structure in antibody cross-reactivity between peptides and folded proteins. J. Mol. Biol. 281:183201.
21. Cwirla, S. E.,, E. A. Peters,, R. W. Barrett,, and W. J. Dower. 1990. Peptides on phage: a vast library of peptides for identifying ligands. Proc. Natl. Acad. Sci. USA 87:63786382.
22. Diakun, K. R.,, and K. L. Matta. 1989. Synthetic antigens as immunogens. Part III. Specificity analysis of an anti-anti-idiotypic antibody to a carbohydrate tumor-associated antigen. J. Immunol. 142:20372040.
23. Evans, S. V.,, D. R. Rose,, R. To,, N. M. Young,, and D. R. Bundle. 1994. Exploring the mimicry of polysaccharide antigens by anti-idiotypic antibodies. The crystallization, molecular replacement, and refinement to 2.8 Å resolution of an idiotope-anti-idiotope Fab complex and of the unliganded anti-idiotope Fab. J. Mol. Biol. 241:691705.
24. Fairhurst, R. M.,, C.-X. Wang,, P. A. Sieling,, R. L. Modlin,, and J. Braun. 1998. CD 1-restricted T cells and resistance to polysaccharide-encapsulated bacteria. Immunol. Today 19:257259.
25. Furuya, A.,, H. Yoshida,, and N. Hanai. 1992. Development of anti-idiotype monoclonal antibodies for sialyl Le(a) antigen. Anticancer Res. 12:2731.
26. Ghiara, J. B.,, D. C. Ferguson,, A. C. Satterthwait,, H. J. Dyson,, and I. A. Wilson. 1997. Structure-based design of a constrained peptide mimic of the HIV-1 V3 loop neutralization site. J. Mol. Biol. 266:3139.
27. Gulati, S.,, D. P. McQuillen,, J. Sharon,, and P. A. Rice. 1996. Experimental immunization with a monoclonal anti-idiotope antibody that mimics the Neisseria gonorrhoeae lipooligosaccharide epitope 2C7. J. Infect. Dis. 174:12381248.
28. Handgretinger, R.,, P. Baader,, R. Dopfer,, T. Klingebiel,, P. Reuland,, J. Treuner,, R. A. Reisfeld,, and D. Niethammer. 1992. A phase I study of neuroblastoma with the anti-ganglioside GD2 antibody 14.G2a. Cancer Immunol. Immunother. 35:199204.
29. Harris, S. L.,, L. Craig,, J. S. Mehroke,, M. Rashed,, M. B. Zwick,, K. Kenar,, E. J. Toone,, N. Greenspan,, F. I. Auzanneau,, A. J. Marino,, B. M. Pinto,, and J. K. Scott. 1997. Exploring the basis of peptide-carbohydrate crossreactivity: evidence for discrimination by peptides between closely related anti-carbohydrate antibodies. Proc. Natl. Acad. Sci. USA 94:24542459.
30. Haurum, J. S.,, G. Arsequell,, A. C. Lellouch,, S. Y. Wong,, R. A. Dwek,, A. J. McMichael,, and T. Elliott. 1994. Recognition of carbohydrate by major histocompatibility complex class I-restricted, glycopeptide-specific cytotoxic T lymphocytes. J. Exp. Med. 180:739744.
31. Haurum, J. S.,, L. Tan,, G. Arsequell,, P. Frodsham,, A. C. Lellouch,, P. A. Moss,, R. A. Dwek,, A. J. McMichael,, and T. Elliott 1995. Peptide anchor residue glycosylation: effect on class I major histocompatibility complex binding and cytotoxic T lymphocyte recognition. Eur. J. Immunol. 25:32703276.
32. Helling, F.,, A. Shang,, M. Calves,, S. Zhang,, S. Ren,, R. K. Yu,, H. F. Oettgen,, and P. O. Livingston. 1994. GD3 vaccines for melanoma: superior immunogenicity of keyhole limpet hemocyanin conjugate vaccines. Cancer Res. 54:197203.
33. Hiemstra, H. S.,, P. A. van Veelen,, S. J. Willemen,, W. E. Benckhuijsen,, A. Geluk,, R. R. de Vries,, B. O. Roep,, and J. W. Drijfhout 1999. Quantitative determination of TCR cross-reactivity using peptide libraries and protein databases. Eur. J. Immunol. 29:23852391.
34. Hoess, R.,, U. Brinkmann,, T. Handel,, and I. Pastan. 1993. Identification of a peptide which binds to the carbohydrate-specific monoclonal antibody B3. Gene 128:4349.
35. Hutchins, W.,, A. Adkins,, T. Kieber-Emmons,, and M. A. J. Westerink. 1996. Molecular characterization of a monoclonal antibody produced in response to a group-C meningococcal polysaccharide peptide mimic. Mol. Immunol. 33:503510.
36. Imberty, A.,, E. Mikros,, J. Koca,, R. Mollincone,, R. Oriol,, and S. Perez. 1995. Computer simulation of histo-blood group oligosaccharides: energy maps of all constituting disaccharides and potential energy surfaces of 14 ABH and Lewis carbohydrate antigens. Glycocon. J. 12:331349.
37. Imberty, A.,, R. Mollicone,, E. Mikros,, P. A. Carrupt,, S. Perez,, and R. Oriol. 1996. How do antibodies and lectins recognize histo-blood group antigens? A 3D-QSAR study by comparative molecular field analysis (CoMFA). Bioorg. Med. Chem. 4:19791988.
38. Imberty, A.,, and S. Perez. 1994. Molecular modelling of protein-carbohydrate interactions. Understanding the specificities of two legume lectins towards oligosaccharides. Glycobiology 4:351366.
39. Jeffrey, P. D.,, J. Bajorath,, C. Y. Chang,, D. Yelton,, I. Hellstrom,, K. E. Hellstrom,, and S. Sheriff. 1995. The X-ray structure of an anti-tumour antibody in complex with antigen. Nat. Struct. Biol. 2:466471.
40. Jensen, T.,, P. Hansen,, S. L. Galli,, S. Mouritsen,, K. Frische,, E. Meinjohanns,, M. Meldal,, and O. Werdelin. 1997. Carbohydrate and peptide specificity of MHC class II-restricted T cell hybridomas raised against an O-glycosylated self peptide. J. Immunol. 158:37693778.
41. Kanda, S.,, H. Takeyama,, Y. Kikumoto,, S. L. Morrison,, D. L. Morton,, and R. F. Irie. 1994. Both VH and VL regions contribute to the antigenicity of anti-idiotypic antibody that mimics melanoma associated ganglioside GM3. Cell Biophys. 2565:6574.
42. Kaur, K. J.,, S. Khurana,, and D. M. Salunke. 1997. Topological analysis of the functional mimicry between a peptide and a carbohydrate moiety. J. Biol. Chem. 272:55395543.
43. Kayhty, H.,, and J. Eskola. 1996. New vaccines for the prevention of pneumococcal infections. Emerg. Infect. Dis. 2:289298.
44. Kieber-Emmons, T.,, B. A. Jameson,, and W. J. Morrow. 1989. The gpl20-CD4 interface: structural, immunological and pathological considerations. Biochim. Biophys. Acta 989:281300.
45. Kieber-Emmons, T.,, P. Luo,, J. Qiu,, T. Y. Chang,, I. O,, M. Blaszczyk-Thurin,, and Z. Steplewski. 1999. Vaccination with carbohydrate peptide mimotopes promotes anti-tumor responses. Nat. Biotechnol. 17:660669.
46. Kieber-Emmons, T.,, M. M. Ward,, R. E. Ward,, and H. Kohler. 1987. Structural considerations in idio-type vaccine design. Monogr. Allergy 22:126133.
47. Klaerner, H. G.,, P. S. Dahlberg,, R. D. Acton,, R. J. Battafarano,, M. E. Uknis,, J. W. Johnston,, and D. L. Dunn. 1997. Immunization with antibodies that mimic LPS protects against gram negative bacterial sepsis. J. Surg. Res. 69:249254.
48. Kudryashov, V.,, G. Ragupathi,, I. J. Kim,, M. E. Breimer,, S. J. Danishefsky,, P. O. Livingston,, and K. O. Lloyd. 1998. Characterization of a mouse monoclonal IgG3 antibody to the tumor-associated globo H structure produced by immunization with a synthetic glycoconjugate. Glycoconj. J. 15:243249.
49. Lane, D. P.,, and C. W. Stephen. 1993. Epitope mapping using bacteriophage peptide libraries. Curr. Opin. Immunol. 5:268271.
50. Lee, D.,, A. Abeyratne,, D. A. Carson,, and M. Corn 1998. Induction of an antigen-specific, CDl-restrict-ed cytotoxic T lymphocyte response in vivo. J. Exp. Med. 187:433438.
51. Lescar, J.,, M. Pellegrini,, H. Souchon,, D. Tello,, R. J. Potfak,, N. Peterson,, M. Greene,, and P. M. Alzari. 1995. Crystal structure of a cross-reaction complex between Fab F9.13.7 and guinea fowl lysozyme. J. Biol. Chem. 270:1806718076.
52. Livingston, P. O. 1995. Approaches to augmenting the immunogenicity of melanoma gangliosides: from whole melanoma cells to ganglioside-KLH conjugate vaccines. Immunol. Rev. 145(147):147166.
53. Longenecker, B. M.,, M. Reddish,, R. Koganty,, and G. D. MacLean. 1993. Immune responses of mice and human breast cancer patients following immunization with synthetic sialyl-Tn conjugated to KLH plus detox adjuvant. Ann. N. Y. Acad. Sci. 690:276291.
54. Longenecker, B. M.,, M. Reddish,, R. Koganty,, and G. D. MacLean. 1994. Specificity of the IgG response in mice and human breast cancer patients following immunization against synthetic sialyl-Tn, an epitope with possible functional significance in metastasis. Adv. Exp. Med. Biol. 353:105124.
55. Lou, Q.,, and I. Pastan. 1999. A Lewis Y epitope mimicking peptide induces anti-Lewis Y immune responses in rabbits and mice. J. Pept. Res. 53:252260.
56. Luo, P.,, M. Agadjanyan,, J.-P. Qiu,, M. A. J. Westerink,, Z. Steplewski,, and T. Kieber-Emmons. 1998. Antigenic and immunological mimicry of peptide mimotopes of Lewis carbohydrate antigens. Mol. Immunol. 35:865879.
57. MacLean, G. D.,, M. Reddish,, R. R. Koganty,, T. Wong,, S. Gandhi,, M. Smolenski,, J. Samuel,, J. M. Nabholtz,, and B. M. Longenecker. 1993. Immunization of breast cancer patients using a synthetic sialyl-Tn glycoconjugate plus Detox adjuvant. Cancer Immunol. Immunother. 36:215222.
58. Mandrell, R. E.,, and M. A. Apicella. 1993. Lipooligosaccharides (LOS) of mucosal pathogens: molecular mimicry and host-modification of LOS. Immunobiology 187:382402.
59. McCool, T. L.,, C. V. Harding,, N. S. Greenspan,, and J. R. Schreiber. 1999. B- and T-cell immune responses to pneumococcal conjugate vaccines: divergence between carrier- and polysaccharide-specific immunogenicity. Infect. Immun. 67:48624869.
60. McNamara, M. K.,, R. E. Ward,, and H. Kohler. 1984. Monoclonal idiotope vaccine against Streptococcus pneumoniae infection. Science 226:13251326.
61. Mer, G.,, E. Kellenberger,, and J. F. Lefevre. 1998. Alpha-helix mimicry of a beta-turn. J. Mol. Biol. 281:235240.
62. Minasian, L. M.,, T. J. Yao,, T. A. Steffens,, D. A. Scheinberg,, L. Williams,, E. Riedel,, A. N. Houghton,, and P. B. Chapman. 1995. A phase I study of anti-GD3 ganglioside monoclonal antibody R24 and recombinant human macrophage-colony stimulating factor in patients with metastatic melanoma. Cancer 75:22512257.
63. Mirkov, T. E.,, S. V. Evans,, J. Wahlstrom,, L. Gomez,, N. M. Young,, and M. J. Chrispeels. 1995. Location of the active site of the bean alpha-amylase inhibitor and involvement of a Trp, Arg, Tyr triad. Glycobiology 5:4550.
64. Monafo, W. J.,, N. S. Greenspan,, T. J. Cebra,, and J. M. Davie. 1987. Modulation of the murine immune response to streptococcal group A carbohydrate by immunization with monoclonal anti-idiotope. J. Immunol. 139:27022707.
65. Mond, J. J.,, A. Lees,, and C. M. Snapper. 1995. T cell-independent antigens type 2. Anna. Rev. Immunol. 13:655692.
66. Monfardini, C.,, T. Kieber-Emmons,, J. M. VonFeldt,, B. O'Malley,, H. Rosenbaum,, A. P. Godillot,, K. Kaushansky,, C. B. Brown,, D. Voet,, D. E. McCallus, et al. 1995. Recombinant antibodies in bioactive peptide design. J. Biol. Chem. 270:66286638.
67. Monfardini, C.,, T. Kieber-Emmons,, D. Voet,, A. P. Godillot,, D. B. Weiner,, and W. V. Williams. 1996. Rational design of granulocyte-macrophage colony-stimulating factor antagonist peptides. J. Biol. Chem. 271:29662971.
68. Moran, A. P.,, M. M. Prendergast,, and B. J. Appelmelk. 1996. Molecular mimicry of host structures by bacterial lipopolysaccharides and its contribution to disease. FEMS Immunol. Med. Microbiol. 16:105115.
69. Morrow, W. J.,, W. M. Williams,, A. S. Whalley,, T. Ryskamp,, R. Newman,, C. Y. Kang,, S. Chamat,, H. Kohler,, and T. Kieber-Emmons. 1992. Synthetic peptides from a conserved region of gpl20 induce broadly reactive anti-HIV responses. Immunology 75:557564.
70. Murai, H.,, S. Hara,, T. Ikenaka,, A. Goto,, M. Arai,, and S. Murao. 1985. Amino acid sequence of protein alpha-amylase inhibitor from Streptomyces griseosporeus YM-25. J. Biochem. 97:11291133.
71. Murali, R.,, and T. Kieber-Emmons. 1997. Molecular recognition of a peptide mimic of the Lewis Y antigen by an anti-Lewis Y antibody. J. Mol. Recognition 10:269276.
72. Oldenburg, K. R.,, D. Loganathan,, I. J. Goldstein,, P. G. Schultz,, and M. A. Gallop. 1992. Peptide lig-ands for a sugar-binding protein isolated from a random peptide library. Proc. Natl. Acad. Sci. USA 89:53935397.
73. Olsson, L. 1987. Molecular mimicry of carbohydrate and protein structures by hybridoma antibodies. Bioessays 7(3):116119.
74. Phalipon, A.,, A. Folgori,, J. Arondel,, G. Sgaramella,, P. Fortugno,, R. Cortese,, P. J. Sansonetti,, and F. Felici. 1997. Induction of anti-carbohydrate antibodies by phage library-selected peptide mimics. Eur. J. Immunol. 27:26202625.
75. Pichla, S. L.,, R. Murali,, and R. M. Burnett 1997. The crystal structure of a Fab fragment to the melanoma-associated GD2 ganglioside. J. Struct. Biol. 119:616.
76. Pincus, S. H.,, M. J. Smith,, H. J. Jennings,, J. B. Burritt,, and P. M. Glee. 1998. Peptides that mimic the group B streptococcal type III capsular polysaccharide antigen. J. Immunol. 160:293298.
77. Pinilla, C.,, J. R. Appel,, G. D. Campbell,, J. Buencamino,, N. Benkirane,, S. Muller,, and N. S. Greenspan. 1998. All-D peptides recognized by an anti-carbohydrate antibody identified from a positional scanning library. J. Mol. Biol. 283:10131025.
78. Pinilla, C.,, S. Chendra,, J. R. Appel,, and R. A. Houghten. 1995. Elucidation of monoclonal antibody polyspecificity using a synthetic combinatorial library. Pep. Res. 8:250257.
79. Prammer, K. V.,, J. Boyer,, K. Ugen,, S. J. Shattil,, and T. Kieber-Emmons. 1994. Bioactive Arg-Gly-Asp conformations in anti-integrin GPiib-iiia antibodies. Receptor 4:93108.
80. Putterman, C.,, and B. Diamond. 1998. Immunization with a peptide surrogate for double-stranded DNA (dsDNA) induces autoantibody production and renal immunoglobulin deposition. J. Exp. Med. 188:2938.
81. Qiu, J.,, P. Luo,, K. Wasmund,, Z. Steplewski,, and T. Kieber-Emmons. 1999. Toward the development of peptide mimotopes of carbohydrate antigens as cancer vaccines. Hybridoma 18:103112.
82. Ravindranath, M. H.,, and D. L. Morton. 1991. Role of gangliosides in active immunotherapy with melanoma vaccine. Int. Rev. Immunol. 7:303329.
83. Raychaudhuri, S.,, C. Y. Kang,, S. V. Kaveri,, T. Kieber-Emmons,, and H. Kohler. 1990. Tumor idiotype vaccines. VII. Analysis and correlation of structural, idiotypic, and biologic properties of protective and nonprotective Ab2. J. Immunol. 145:760767.
84. Ritter, G.,, B. E. Ritter,, R. Adluri,, M. Calves,, S. Ren,, R. K. Yu,, H. F. Oettgen,, L. J. Old,, and P. O. Livingston. 1995. Analysis of the antibody response to immunization with purified O-acetyl GD3 gangliosides in patients with malignant melanoma. Int. J. Cancer 62:668672.
85. Saleh, M. N.,, M. B. Khazaeli,, R. H. Wheeler,, L. Allen,, A. B. Tilden,, W. Grizzle,, R. A. Reisfeld,, A. L. Yu,, S. D. Gillies,, and A. F. LoBuglio. 1992. Phase I trial of the chimeric anti-GD2monoclonal antibody ch 14.18 in patients with malignant melanoma. Hum. Antibodies Hybridomas 3:1924.
86. Saleh, M. N.,, M. B. Khazaeli,, R. H. Wheeler,, E. Dropcho,, T. Liu,, M. Urist,, D. M. Miller,, S. Lawson,, P. Dixon,, C. H. Russell, et al. 1992. Phase I trial of the murine monoclonal anti-GD2 antibody 14G2a in metastatic melanoma. Cancer Res. 52:43424347.
87. Saleh, M. N.,, J. D. Stapleton,, M. B. Khazaeli,, and A. F. LoBuglio. 1993. Generation of a human anti-idiotypic antibody that mimics the GD2 antigen. J. Immunol. 151:33903398.
88. Schmolling, J.,, J. Reinsberg,, U. Wagner,, and D. Krebs. 1995. Antiidiotypic antibodies in ovarian cancer patients treated with the monoclonal antibody B72.3. Hybridoma 14:183186.
89. Schofield, L.,, M. J. McConville,, D. Hansen,, A. S. Campbell,, B. Fraser-Reid,, M. J. Grusby,, and S. D. Tachado. 1999. CD ld-restricted immunoglobulin G formation to GPI-anchored antigens mediated by NKT cells. Science 283:225229.
90. Schreiber, J. R.,, K. L. Nixon,, M. F. Tosi,, G. B. Pier,, and M. B. Patawaran. 1991. Anti-idiotype-induced, lipopolysaccharide-specific antibody response to Pseudomonas aeruginosa. II. Isotype and functional activity of the anti-idiotype-induced antibodies. J. Immunol. 146:188193.
91. Schreiber, J. R.,, M. Patawaran,, M. Tosi,, J. Lennon,, and G. B. Pier. 1990. Anti-idiotype-induced, lipopolysaccharide-specific antibody response to Pseudomonas aeruginosa. J. Immunol. 144:10231029.
92. Schreiber, J. R.,, G. B. Pier,, M. Grout,, K. Nixon,, and M. Patawaran. 1991. Induction of opsonic antibodies to Pseudomonas aeruginosa mucoid exopolysaccharide by an anti-idiotypic monoclonal antibody. J. Infect. Dis. 164:507514.
93. Scott, J. K. 1992. Discovering peptide ligands using epitope libraries. Trends Biochem. Sci. 17:241245.
94. Scott, J. K.,, D. Loganathan,, R. B. Easley,, X. Gong,, and I. J. Goldstein. 1992. A family of concanavalin A-binding peptides from a hexapeptide epitope library. Proc. Natl. Acad. Sci. USA 89:53985402.
95. Scott, J. K.,, and G. P. Smith. 1990. Searching for peptide ligands with an epitope library. Science 249:386390.
96. Sen, G.,, M. Chakraborty,, K. A. Foon,, R. A. Reisfeld,, and C. M. Bhattacharya. 1998. Induction of IgG antibodies by an anti-idiotype antibody mimicking disialoganglioside GD2. J. Immunother. 21:7583.
97. Shikhman, A. R.,, and M. W. Cunningham. 1994. Immunological mimicry between Af-acetyl-beta-D-glucosamine and cytokeratin peptides. Evidence for a microbially driven anti-keratin antibody response. J. Immunol. 152:43754387.
98. Shikhman, A. R.,, N. S. Greenspan,, and M. W. Cunningham. 1994. Cytokeratin peptide SFGS-GFGGGY mimics N-acetyl-beta-D;-glucosamine in reaction with antibodies and lectins, and induces in vivo anti-carbohydrate antibody response. J. Immunol. 153:55935606.
99. Shikhman, A. R.,, and M. W. Cunningham. 1997. Trick and treat: toward peptide mimic vaccines. Nat. Biotechnol. 15:512513.
100. Smith, G. P.,, and J. K. Scott. 1993. Libraries of peptides and proteins displayed on filamentous phage. Methods Enzymol. 217:228257.
101. Stein, K. E.,, and T. Soderstrom. 1984. Neonatal administration of idiotype or antiidiotype primes for protection against Escherichia coli K13 infection in mice. J. Exp. Med. 160:10011011.
102. Stern, B.,, G. Denisova,, D. Buyaner,, D. Raviv,, and J. M. Gershoni. 1997. Helical epitopes determined by low-stringency antibody screening of a combinatorial peptide library. FASEB J. 11:147153.
102a. Sugita, M.,, D. B. Moody,, R. M. Jackman,, E. P. Grant,, J. P. Rosat,, S. M. Behar,, P. J. Peters,, S. A. Porcelli,, and M. B. Brenner. 1998. CD1: a new paradigm for antigen presentation and T-cell activation. Clin. Immunol. Immunopathol. 87:814.
103. Taki, T.,, D. Ishikawa,, H. Hamasaki,, and S. Handa. 1997. Preparation of peptides which mimic glycosphingolipids by using phage peptide library and their modulation on beta-galactosidase activity. FEBS Lett. 418:219223.
104. Thurin, J.,, M. Thurin,, Y. Kimoto,, M. Herlyn,, M. D. Lubeck,, D. E. Elder,, M. Smereczynska,, K. A. Karlsson,, W. M. J. Clark,, and Z. Steplewski. 1987. Monoclonal antibody-defined correlations in melanoma between levels of GD2 and GD3 antigens and antibody-mediated cytotoxicity. Cancer Res. 47:12291233.
105. Thurin-BIaszczyk, M.,, R. Murali,, M. A. J. Westerink,, Z. Steplewski,, M.-S. Co,, and T. Kieber-Emmons. 1996. Molecular recognition of the Lewis Y antigen by monoclonal antibodies. Protein Eng. 9:101113.
106. Transue, T. R.,, E. De Genst,, M. A. Ghahroudi,, L. Wyns,, and S. Muyldermans. 1998. Camel single-domain antibody inhibits enzyme by mimicking carbohydrate substrate. Proteins 32:515522.
107. Tsuyuoka, K.,, K. Yago,, K. Hirashima,, S. Ando,, N. Hanai,, H. Saito,, K. M. Yamasaki,, K. Takahashi,, Y. Fukuda,, K. Nakao,, and R. Kannagi. 1996. Characterization of a T cell line specific to an anti-Id antibody related to the carbohydrate antigen, sialyl SSEA-1, and the immunodominant T cell antigenic site of the antibody. J. Immunol. 157:661669.
108. Valadon, P.,, G. Nussbaum,, L. F. Boyd,, D. H. Margulies,, and M. D. Scharff. 1996. Peptide libraries define the fine specificity of anti-polysaccharide antibodies to Cryptococcus neoformans. J. Mol. Biol. 261:1122.
109. Valadon, P.,, and M. D. Scharff. 1996. Enhancement of ELISAs for screening peptides in epitope phage display libraries. J. Immunol. Methods 197:171179.
110. Viale, G.,, F. Grassi,, M. Pelagi,, R. Alzani,, S. Menard,, S. Miotti,, R. Buffa,, A. Gini,, and A. G. Siccardi. 1987. Anti-human tumor antibodies induced in mice and rabbits by “internal image” anti-idiotypic monoclonal immunoglobulins. J. Immunol. 139:42504255.
111. Westerink, M. A.,, A. A. Campagnari,, M. A. Wirth,, and M. A. Apicella. 1988. Development and characterization of an anti-idiotype antibody to the capsular polysaccharide of Neisseria meningitidis serogroup C. Infect. Immun. 56:11201127.
112. Westerink, M. A. J.,, P. C. Giardina,, M. A. Apicella,, and T. Kieber-Emmons. 1995. Peptide mimicry of the meningococcal group C capsular polysaccharide. Proc. Natl. Acad. Sci. USA 92:40214025.
113. Williams, W. V.,, T. Kieber-Emmons,, J. Von Feldt,, M. I. Greene,, and D. B. Weiner. 1991. Design of bioactive peptides based on antibody hypervariable region structures. Development of conformationally constrained and dimeric peptides with enhanced affinity. J. Biol. Chem. 266:51825190.
114. Williams, W. V.,, T. Kieber-Emmons,, D. B. Weiner,, D. H. Rubin,, and M. I. Greene. 1991. Contact residues and predicted structure of the reovirus type 3-receptor interaction. J. Biol. Chem. 266:92419250.
115. Williams, W. V.,, D. A. Moss,, T. Kieber-Emmons,, J. A. Cohen,, J. N. Myers,, D. B. Weiner,, and M. I. Greene. 1989. Development of biologically active peptides based on antibody structure. Proc. Natl. Acad. Sci. USA 86:55375541. (Erratum, 86:8044.)
116. Young, A. C.,, P. Valadon,, A. Casadevall,, M. D. Scharff,, and J. C. Sacchettini. 1997. The three-dimensional structures of a polysaccharide binding antibody to Cryptococcus neoformans and its complex with a peptide from a phage display library: implications for the identification of peptide mimotopes. J. Mol. Biol. 274:622634.
117. Young, N. M.,, M. A. Gidney,, B. M. Gudmundsson,, C. R. MacKenzie,, R. To,, D. C. Watson,, and D. R. Bundle. 1999. Molecular basis for the lack of mimicry of Brucella polysaccharide antigens by Ab2gamma antibodies. Mol. Immunol. 36:339347.
118. Zhang, H.,, Z. Zhong,, and L. A. Pirofski. 1997. Peptide epitopes recognized by a human anti-cryptococcal glucuronoxylomannan antibody. Infect. Immun. 65:11581164.
119. Zhang, S.,, L. A. Walberg,, S. Ogata,, S. H. Itzkowitz,, R. R. Koganty,, M. Reddish,, S. S. Gandhi,, B. M. Longenecker,, K. O. Lloyd,, and P. O. Livingston. 1995. Immune sera and monoclonal antibodies define two configurations for the sialyl Tn tumor antigen. Cancer Res. 55:33643368.
120. Zhao, R.,, D. J. Loftus,, E. Appella,, and E. J. Collins. 1999. Structural evidence of T cell xeno-reactivity in the absence of molecular mimicry. J. Exp. Med. 189:359370.


Generic image for table
Table 1

Carbohydrate-based vaccines licensed or under development for bacteria and cancer

Citation: Cunto-Amesty G, Kieber-Emmons T. 2000. Exploiting Molecular Mimicry in Targeting Carbohydrate Antigens, p 175-196. In Cunningham M, Fujinami R (ed), Molecular Mimicry, Microbes, and Autoimmunity. ASM Press, Washington, DC. doi: 10.1128/9781555818074.ch13
Generic image for table
Table 2

Pneumococcal conjugate vaccines in phase II and phase III trials

Citation: Cunto-Amesty G, Kieber-Emmons T. 2000. Exploiting Molecular Mimicry in Targeting Carbohydrate Antigens, p 175-196. In Cunningham M, Fujinami R (ed), Molecular Mimicry, Microbes, and Autoimmunity. ASM Press, Washington, DC. doi: 10.1128/9781555818074.ch13
Generic image for table
Table 3

Peptide motifs that mimic carbohydrate structures

Citation: Cunto-Amesty G, Kieber-Emmons T. 2000. Exploiting Molecular Mimicry in Targeting Carbohydrate Antigens, p 175-196. In Cunningham M, Fujinami R (ed), Molecular Mimicry, Microbes, and Autoimmunity. ASM Press, Washington, DC. doi: 10.1128/9781555818074.ch13
Generic image for table
Table 4

Peptides described in our previous studies

Citation: Cunto-Amesty G, Kieber-Emmons T. 2000. Exploiting Molecular Mimicry in Targeting Carbohydrate Antigens, p 175-196. In Cunningham M, Fujinami R (ed), Molecular Mimicry, Microbes, and Autoimmunity. ASM Press, Washington, DC. doi: 10.1128/9781555818074.ch13
Generic image for table
Table 5

Similarities among neolactoseries constituents

Citation: Cunto-Amesty G, Kieber-Emmons T. 2000. Exploiting Molecular Mimicry in Targeting Carbohydrate Antigens, p 175-196. In Cunningham M, Fujinami R (ed), Molecular Mimicry, Microbes, and Autoimmunity. ASM Press, Washington, DC. doi: 10.1128/9781555818074.ch13
Generic image for table
Table 6

Secondary structure profiles of various MAb BR55-2-reactive and nonreactive peptides

Citation: Cunto-Amesty G, Kieber-Emmons T. 2000. Exploiting Molecular Mimicry in Targeting Carbohydrate Antigens, p 175-196. In Cunningham M, Fujinami R (ed), Molecular Mimicry, Microbes, and Autoimmunity. ASM Press, Washington, DC. doi: 10.1128/9781555818074.ch13
Generic image for table
Table 7

Kinetic analysis of ligand binding to MAb BR55-2

Citation: Cunto-Amesty G, Kieber-Emmons T. 2000. Exploiting Molecular Mimicry in Targeting Carbohydrate Antigens, p 175-196. In Cunningham M, Fujinami R (ed), Molecular Mimicry, Microbes, and Autoimmunity. ASM Press, Washington, DC. doi: 10.1128/9781555818074.ch13
Generic image for table
Table 8

Glycosphingolipid constituents shared among bacteria and tumor cells

Citation: Cunto-Amesty G, Kieber-Emmons T. 2000. Exploiting Molecular Mimicry in Targeting Carbohydrate Antigens, p 175-196. In Cunningham M, Fujinami R (ed), Molecular Mimicry, Microbes, and Autoimmunity. ASM Press, Washington, DC. doi: 10.1128/9781555818074.ch13

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error